相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Advances in research on virulence factors of Acinetobacter baumannii and their potential as novel therapeutic targets
Jian-Xia Zhou et al.
JOURNAL OF APPLIED MICROBIOLOGY (2023)
Mortality predictors on the day of healthcare-associated Acinetobacter baumanni bacteremia in intensive care unit
Murat Emre Tokur et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2022)
Differentiation Between Acinetobacter Baumannii Colonization and Infection and the Clinical Outcome Prediction by Infection in Lower Respiratory Tract
Ding-Yun Feng et al.
INFECTION AND DRUG RESISTANCE (2022)
Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case-control study
Yihai Gu et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)
Pathogenesis of Gram-Negative Bacteremia
Caitlyn L. Holmes et al.
CLINICAL MICROBIOLOGY REVIEWS (2021)
Acinetobacter baumannii: An Ancient Commensal with Weapons of a Pathogen
Meysam Sarshar et al.
PATHOGENS (2021)
Comparative analysis of carbapenemases, RND family efflux pumps and biofilm formation potential among Acinetobacter baumannii strains with different carbapenem susceptibility
Yanpeng Zhang et al.
BMC INFECTIOUS DISEASES (2021)
An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation
Hing Jian Mea et al.
MICROBIOLOGICAL RESEARCH (2021)
Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals
Susan Ibrahim et al.
MOLECULAR BIOLOGY REPORTS (2021)
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
Scott L. Weiss et al.
PEDIATRIC CRITICAL CARE MEDICINE (2020)
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
Elodie von Dach et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
Rosalino Vazquez-Lopez et al.
ANTIBIOTICS-BASEL (2020)
Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in Acinetobacter baumannii complex bacteraemia: experience from the Chinese Antimicrobial Resistance Surveillance of Nosocomial Infections (CARES) Network
Yudong Liu et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2020)
Host Innate Immune Responses toAcinetobacter baumanniiInfection
Wangxue Chen
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study
Alessandro Russo et al.
JOURNAL OF INFECTION (2019)
Risk factors for mortality due to Acinetobacter baumannii bacteremia in patients with hematological malignancies - a retrospective study
Liat Shargian-Alon et al.
LEUKEMIA & LYMPHOMA (2019)
Risk Factors for Mortality in Children with Acinetobacter baumannii Bacteremia in South Korea: The Role of Carbapenem Resistance
Young June Choe et al.
MICROBIAL DRUG RESISTANCE (2019)
Platelets Are Critical Key Players in Sepsis
Fanny Vardon-Bounes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection
Ana Flores-Mireles et al.
TOPICS IN SPINAL CORD INJURY REHABILITATION (2019)
Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology
X. Wang et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Risk factors and outcomes of hospitalized patients with blood infections caused by multidrug-resistant Acinetobacter baumannii complex in a hospital of Northern China
Ninghui Guo et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2016)
Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections
Ruthy Tal-Jasper et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy
Ji-Yong Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis
Aline C. Q. Leao et al.
BMC INFECTIOUS DISEASES (2016)
Risk Factors and Clinical Outcomes for Patients With Acinetobacter baumannii Bacteremia
Zhenyang Gu et al.
MEDICINE (2016)
Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis
Md Saruar Bhuiyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study
O. Henig et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
An update on prevention and treatment of catheter-associated urinary tract infections
Peter Tenke et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
Risk factors for carbapenem-resistant Acinetobacter baumanii blood stream infections in a neonatal intensive care unit, Delhi, India
Ajay Kumar et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2014)
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study
Alexis Tabah et al.
INTENSIVE CARE MEDICINE (2012)
Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia
Shih-Tse Huang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2012)
Innate Immune Responses to Systemic Acinetobacter baumannii Infection in Mice: Neutrophils, but Not Interleukin-17, Mediate Host Resistance
Jessica M. Breslow et al.
INFECTION AND IMMUNITY (2011)